23
Participants
Start Date
July 31, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
insulin detemir
Treat-to-target dose tritation (dose adjusted individually), s.c. (under the skin) injection
insulin NPH
Treat-to-target dose tritation (dose adjusted individually), s.c. (under the skin) injection
insulin aspart
Treat-to-target dose tritation (dose adjusted individually), s.c. (under the skin) injection
Novo Nordisk Investigational Site, Guildford
Lead Sponsor
Novo Nordisk A/S
INDUSTRY